A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
44 locations incl. Mobile
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female·Age: 18+
Code: NCT05128825·Phase 2·Recruiting